Trial Profile
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Pinitol (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 14 Oct 2016 Status changed from recruiting to completed.
- 14 Oct 2016 Status changed from recruiting to completed.
- 02 Sep 2013 New source identified and integrated: ClinicalTrials.gov record.